Deutsches Diabetes-Zentrum

What Deutsches Diabetes-Zentrum does

Deutsches Diabetes-Zentrum (DDZ) is an interdisciplinary non-profit research institute headquartered in Düsseldorf, Germany, founded in 1965 and legally operated by Deutsche Diabetes Forschungsgesellschaft e.V. It functions as the Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf and is a member of the German Center for Diabetes Research (DZD). The institute conducts molecular, clinical, epidemiological, and health-services research on diabetes and its complications, organized into five institutes (Clinical Diabetology, Clinical Biochemistry and Pathobiochemistry, Biometry and Epidemiology, Vascular and Islet Cell Biology, and Health Services Research and Health Economics), plus the National Diabetes Information Center and the Computational Diabetology group.

Its public-facing portfolio includes the national diabetes information portal diabinfo.de (co-operated with Helmholtz Munich and DZD), the Diabetes-Cockpit risk-assessment tool, the Diabetes-Uhr prevalence dashboard, the Wegweiser RIN Diabetes regional service directory with over 150 providers, clinical study enrollment at its DIN EN ISO 9001:2015-certified Clinical Research Center, and an in-person self-help group operating since 2001. Core technology centers on bioinformatics for multi-omics and clinical-data integration, pangenome-based disease-variant analysis, and platforms for proteomics, genomics, and cell morphology.

The institute does not sell commercial products or services and operates on a non-profit funding model. Revenue derives from institutional grants from the Federal Ministry of Health (BMG) and the NRW Ministry for Culture and Science, project funding from the GBA Innovation Fund and BZgA, and competitive third-party research grants. End-users include people with diabetes, relatives, clinical study participants, physicians, and healthcare professionals, served primarily through digital platforms, regional networks in Greater Düsseldorf, and the national information portal.

Name

Deutsches Diabetes-Zentrum

Legal name

Deutsche Diabetes Forschungsgesellschaft e.V.

Website

https://ddz.de

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

101–250 employees

Short description

Deutsches Diabetes-Zentrum (DDZ) is a Düsseldorf-based, non-profit Leibniz research institute conducting interdisciplinary diabetes research and operating national information, clinical-trial, and regional care-navigation services for patients, clinicians, and the German public.

Ownership category

akta.pro rank

Product category

Diabetes Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Diabetes (General) (HLAKADAA)

akta.pro secondary industries

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM), Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN)

Keywords

• Diabetes research
• Clinical studies
• Biomedical research
• Health services research
• Epidemiology research

Headquarters

HQ city

Düsseldorf

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Government Research Funding: As a Leibniz Association research center affiliated with Heinrich Heine University Düsseldorf, the DDZ receives institutional funding from government sources including the Bundesministerium für Gesundheit (BMG) and Ministerium für Kultur und Wissenschaft NRW.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

The Deutsches Diabetes-Zentrum (DDZ) is a non-profit interdisciplinary research center conducting molecular, clinical, and epidemiological research on diabetes mellitus and its complications. It delivers patient- and public-facing services including clinical study participation, a national diabetes information portal (diabinfo.de), the Diabetes-Cockpit personal health risk assessment tool, the Diabetes-Uhr prevalence statistics tool, a regional care services directory (Wegweiser RIN Diabetes), and an on-site self-help group for people with diabetes.

Product overview

Deutsches Diabetes-Zentrum operates as a unified research institution offering a portfolio of diabetes-related information and patient services rather than a software product platform. The core offerings include the Diabetes-Cockpit for personal health risk assessment (evaluating BMI, blood pressure, and blood sugar), the Diabetes-Uhr for public statistics on diabetes prevalence, and the Diabetesinformationsportal (diabinfo.de) as a comprehensive national information resource on diabetes and its complications. Patient-facing services include clinical study participation and the Wegweiser RIN Diabetes directory for finding local care providers. A self-help group provides ongoing peer support for people with diabetes.

Differentiator

Problem solved

Functional benefit

Brands

• diabinfo.de: National Diabetes Information Portal operated by the National Diabetes Information Center in cooperation with Helmholtz Center Munich and German Center for Diabetes Research (DZD)
• Diabetes-Cockpit
• Diabetes-Uhr

Products and services

• Diabetes-Cockpit A self-assessment tool that provides an overview for evaluating BMI, blood pressure, and blood sugar levels to estimate individual diabetes risk, for use by the general public and people with diabetes.
• Diabetes-Uhr (Diabetes Clock) An interactive statistics tool showing current and projected diabetes prevalence in Germany, including projections of up to 12 million people with diabetes by 2040, aimed at the general public.
• diabinfo.de National Diabetes Information Portal A national diabetes information portal providing quality-assured information on diabetes, early detection, prevention, diagnosis, and treatment of secondary diseases, operated jointly with Helmholtz Center Munich and DZD for the general public, doctors, and professionals.
• Clinical Studies at DDZ (Klinische Studien) Participation in clinical trials conducted at the DDZ to advance diabetes research, with eligibility screening and monetary compensation for participants; offered to both people with diabetes and non-diabetic control subjects.
• Wegweiser RIN Diabetes An interactive search tool with map functionality to find local prevention, counseling, and healthcare services for diabetes in the Greater Düsseldorf area, featuring over 150 relevant offerings.
• Self-Help Group at DDZ (Selbsthilfegruppe) A peer support group for people with diabetes meeting at DDZ since October 2001, providing information on diabetes treatment and personal therapy experiences.

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

24 partnerships are on record, tiered core, major and minor.

• Leibniz-Gemeinschaft (Leibniz Association)coreStrategic or Co-development PartnerThe DDZ is a member of the Leibniz Association, a network of non-university research institutions. This affiliation provides institutional funding, research collaboration opportunities, and academic credibility across Germany's research landscape.
• Heinrich-Heine-Universität DüsseldorfcoreStrategic or Co-development PartnerThe DDZ is formally affiliated with Heinrich Heine University Düsseldorf as the 'Leibniz Center for Diabetes Research'. This provides academic integration, student access, and research collaboration with university departments including the Medical Faculty.
• Universitätsklinikum Düsseldorf (University Hospital Düsseldorf)coreStrategic or Co-development PartnerClinical collaboration with the University Hospital Düsseldorf, specifically the Clinic for Endocrinology and Diabetology. The Paul-Langerhans-Group Computational Diabetology is part of this department.
• Deutsches Zentrum für Diabetesforschung e.V. (DZD)coreStrategic or Co-development PartnerThe DDZ collaborates with the German Center for Diabetes Research (DZD), jointly operating the National Diabetes Information Portal diabinfo.de. DZD is a national research consortium focused on diabetes.
• Human Pangenome Reference ConsortiummajorTechnology or IntegrationCollaboration on pangenome-based research approaches to study disease-related genetic variations, particularly in complex loci relevant to diabetes.
• University of Virginia, Charlottesville, USmajorStrategic or Co-development PartnerResearch collaboration with Prof. K. Walsh and Prof. C. Miller from University of Virginia in the field of computational diabeteology.
• Helmholtz Zentrum MünchencoreStrategic or Co-development PartnerJoint operation of the National Diabetes Information Portal diabinfo.de with Helmholtz Center Munich and DZD.
• KORA (Kooperative Gesundheitsforschung in der Region Augsburg)majorStrategic or Co-development PartnerCollaboration with the KORA study based in Augsburg for population-based diabetes research, including studies on patient time costs and information needs.
• Klinik für Kardiologie, Angiologie und Pneumologie, Universitätsklinikum DüsseldorfmajorStrategic or Co-development PartnerCollaboration on the Düsseldorf STEMI study examining myocardial infarction as complication of diabetes.
• Max-Planck-Institut für Öffentliche Güter, BonnmajorStrategic or Co-development PartnerCollaboration on the Düsseldorf STEMI study examining patient preferences after myocardial infarction.
• Institut für Neurowissenschaften, Universitätsklinikum DüsseldorfmajorStrategic or Co-development PartnerCollaboration on neuroscience aspects of diabetes research.
• AOK Rheinland/Hamburg – Die GesundheitskassemajorStrategic or Co-development PartnerConsortium leadership for the TeLIPro project evaluating telemedical lifestyle intervention programs for people with type 2 diabetes.
• Deutsches Institut für Telemedizin und Gesundheitsförderung GmbH (DITG)majorStrategic or Co-development PartnerPartner in the TeLIPro project for telemedical lifestyle interventions.
• Privates Institut für angewandte Versorgungsforschung GmbH (inav)minorStrategic or Co-development PartnerPartner in the TeLIPro project.
• Kassenärztliche Vereinigung NordrheinmajorStrategic or Co-development PartnerPartner in the TeLIPro project for telemedical lifestyle interventions.
• Forschungsinstitut an der Diabetes-Akademie (FIDAM) Bad MergentheimmajorStrategic or Co-development PartnerCollaboration on the DIAMOS study evaluating cognitive-behavioural therapy for patients with type 2 diabetes and subclinical depression.
• Klinik für Psychosomatik und Psychotherapie, Universität GießenmajorStrategic or Co-development PartnerCollaboration on the DIAMOS study for diabetes-specific cognitive behavioural therapy research.
• Paul Langerhans Institut Tübingen für Diabetesforschung und Metabolische ErkrankungenmajorStrategic or Co-development PartnerLead institution for the PLIS study on pre-diabetes lifestyle intervention, part of the Helmholtz Zentrum München.
• Medizinische Klinik IV, Universität TübingenmajorStrategic or Co-development PartnerCollaboration on the PLIS study for health economic evaluation of pre-diabetes lifestyle intervention.
• Department for Psychosomatic Medicine and Psychotherapy, Center for Health Communication and Health Services Research, University Hospital of BonnmajorStrategic or Co-development PartnerCollaboration on assessment of information needs amongst people with diabetes mellitus.
• Institut für Gesundheitsökonomie und Management im Gesundheitswesen, Helmholtz Zentrum MünchenmajorStrategic or Co-development PartnerCollaboration on KORA study research on information needs and diabetes.
• Forschungsstelle für Gesundheitskommunikation und Versorgungsforschung, Universitätsklinikum BonnmajorStrategic or Co-development PartnerCollaboration on diabetes information needs research using KORA study data.
• Institut für Allgemeinmedizin, Centre for Health and Society, Medizinische Fakultät, Heinrich-Heine-Universität DüsseldorfmajorStrategic or Co-development PartnerCollaboration on identifying needs and demands of people with diabetes for diabetes research.
• CINCH –Forschungszentrum für Gesundheitsökonomik, Universität Duisburg-EssenmajorStrategic or Co-development PartnerCollaboration on BARIA-DDZ study examining changes in patient preferences after bariatric surgery.

Scale indicators3 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• German Center for Diabetes Research (DZD e.V.): National German diabetes research consortium of which DDZ is a member; comparable as it coordinates multi-site translational diabetes research across the same funding streams and scientific agenda.
• Novo Nordisk Foundation Center for Basic Metabolic Research: University of Copenhagen center for metabolic and diabetes research; comparable as a European academic center conducting molecular, clinical and translational diabetes research.
• Steno Diabetes Center Copenhagen: Major European diabetes research and clinical care center; comparable as a non-university specialty center conducting integrated clinical, epidemiological and translational diabetes research at national scale.
• Helmholtz Zentrum München (HMGU) - Institute for Diabetes Research and Metabolic Diseases: Co- operator of the national diabinfo.de portal with DDZ and a fellow DZD node; comparable as a German diabetes research center conducting molecular, clinical and translational diabetes research at similar scale.
• Paul Langerhans Institut Tübingen (PLID): DDZ's namesake peer and DZD partner; comparable as a German university-affiliated diabetes research center combining islet cell biology, clinical trials and translational research.
• Joslin Diabetes Center: Harvard-affiliated US diabetes research and clinical care center; comparable as a long-standing specialty institution combining laboratory, clinical and educational missions in diabetes.
• Profil Institut für Stoffwechselforschung: German clinical research organization specializing in metabolic disease and diabetes trials; comparable for its focus on diabetes clinical study operations and patient cohorts in Germany.

Others

• International Diabetes Federation (IDF): Global diabetes advocacy and research umbrella organization; comparable as a coordinating body in diabetes information dissemination, policy and epidemiological surveillance that DDZ engages with through diabinfo.de.

Broad incumbents

• Karolinska Institutet - Endocrinology and Diabetes Research: Large Swedish academic medical institution; comparable for its diabetes epidemiology, clinical trials and translational endocrinology research at national scale.
• German Institute of Human Nutrition (DIfE) Potsdam-Rehbrücke: Leibniz Association member and DZD partner; comparable as a larger nutrition-and-metabolism research institute with overlapping diabetes epidemiology and intervention research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/deutsches-diabetes-zentrum
• Instagraminstagram.com/deutsches_diabetes_zentrum

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deutsches Diabetes-Zentrum